Sunbird Bio

Developer of blood-based diagnostic tests for neurological disorders

placeSingapore calendar_todayFounded 2020 groups12 employees language sunbirdbio.com

Registered entities

Innovation

9 patent families (1 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace active. Cited 938 times.

YearFilings
20244
20258
20261

Investor mix

10 investors on record; lead investors include Lilly, EDBI, Clavystbio, Polaris Partners.

Investor typeCountShare
Venture capital440%
Private equity110%
Other / undisclosed550%
Coming soon